Physician profile
Bruce K Smith
NPI 1821191859
$3,620.08
in general payments reported to CMS, 2019-2025
14 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $101 · 2021: $336 · 2022: $803 · 2023: $870 · 2024: $552 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,040.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $750.40 | 2021-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $414.87 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $376.65 | 2023-2025 | |
| Davol INC. | $357.12 | 2019-2022 | |
| Allergan, INC. | $311.44 | 2019-2022 | |
| Axogen | $244.83 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Abbvie INC. | $226.56 | 2023-2025 | Alloderm |
| Motiva USA, LLC | $209.15 | 2024-2025 | |
| Tela Bio, INC. | $166.55 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $146.65 | 2023 | Durasorb Monofilament Mesh |
| Kerecis Limited | $135.12 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $112.51 | 2023 | Matrixmandible |
| Coopersurgical, INC. | $100.94 | 2020 | |
| Rti Surgical, INC | $67.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.